Multi-omics landscape of circadian rhythm pathway alterations in Glioma

References

• Hastings MH, Maywood ES, Brancaccio M. Generation of circadian rhythms in the suprachiasmatic nucleus. Nat Rev Neurosci. 2018;19:453–469.
   PubMed Web of Science ®Google Scholar
• Zhou Y, Wu M, Xu L, et al. Bmal1 regulates macrophage polarize through glycolytic pathway in alcoholic liver disease. Front Pharmacol. 2021;12:640521.
   PubMed Web of Science ®Google Scholar
• Xu L, Yang TY, Zhou YW, et al. Bmal1 inhibits phenotypic transformation of hepatic stellate cells in liver fibrosis via IDH1/alpha-KG-mediated glycolysis. Acta Pharmacol Sin. 2021. https://doi.org/10.1038/s41401-021-00658-9.
   Web of Science ®Google Scholar
• Wang XL, Wolff SEC, Korpel N, et al. Deficiency of the circadian clock gene Bmal1 reduces microglial immunometabolism. Front Immunol. 2020;11:586399.
   PubMed Web of Science ®Google Scholar
• Wang XL, Kooijman S, Gao Y, et al. Microglia-specific knock-down of Bmal1 improves memory and protects mice from high fat diet-induced obesity. Mol Psychiatry. 2021. https://doi.org/10.1038/s41380-021-01169-z.
   Web of Science ®Google Scholar
• Tobelmann D, Dittmar M. Diurnal relationship between core clock gene BMAL1, antioxidant SOD1 and oxidative RNA/DNA damage in young and older healthy women. Exp Gerontol. 2021;151:111422.
   PubMed Web of Science ®Google Scholar
• Lee SB, Park J, Kwak Y, et al. Disrupted-in-schizophrenia 1 enhances the quality of circadian rhythm by stabilizing BMAL1. Transl Psychiatry. 2021;11:110.
   PubMed Web of Science ®Google Scholar
• Masri S, Sassone-Corsi P. The emerging link between cancer, metabolism, and circadian rhythms. Nat Med. 2018;24:1795–1803.
   PubMed Web of Science ®Google Scholar
• Arafa K, Emara M. Insights About Circadian Clock and Molecular Pathogenesis in Gliomas. Front Oncol. 2020;10:199.
   PubMed Web of Science ®Google Scholar
• Viswanathan AN, Hankinson SE, Schernhammer ES. Night shift work and the risk of endometrial cancer. Cancer Res. 2007;67:10618–10622.
   PubMed Web of Science ®Google Scholar
• Conlon M, Lightfoot N, Kreiger N. Rotating shift work and risk of prostate cancer. Epidemiology. 2007;18:182–183.
   PubMed Web of Science ®Google Scholar
• Molinaro AM, Taylor JW, Wiencke JK, et al. Genetic and molecular epidemiology of adult diffuse glioma. Nat Rev Neurol. 2019;15:405–417.
   PubMed Web of Science ®Google Scholar
• Chen Z, Liu P, Li C, et al. Deregulated expression of the clock genes in gliomas. Technol Cancer Res Treat. 2013;12:91–97.
   PubMed Web of Science ®Google Scholar
• Huang Z, Zhao X, Wu X, et al. LncRNA UCA1 facilitated cell growth and invasion through the miR-206/CLOCK axis in glioma. Cancer Cell Int. 2019;19:316.
   PubMed Web of Science ®Google Scholar
• Jung CH, Kim EM, Park JK, et al. Bmal1 suppresses cancer cell invasion by blocking the phosphoinositide 3-kinase-Akt-MMP-2 signaling pathway. Oncol Rep. 2013;29:2109–2113.
   PubMed Web of Science ®Google Scholar
• Pistioli L, Katsarelias D, Audisio RA, et al. The intricate relationship between melatonin and breast cancer: a short review. Chirurgia (Bucur). 2021;116:24–34.
   PubMed Web of Science ®Google Scholar
• Maleki M, Khelghati N, Alemi F, et al. Multiple Interactions between melatonin and non-coding RNA in cancer biology. Chem Biol Drug Des. 2021. https://doi.org/10.1111/cbdd.13849.
   Web of Science ®Google Scholar
• Jafari-Koulaee A, Bagheri-Nesami M. The effect of melatonin on sleep quality and insomnia in patients with cancer: a systematic review study. Sleep Med. 2021;82:96–103.
   PubMed Web of Science ®Google Scholar
• Chao YC, Lee KY, Wu SM, et al. Melatonin downregulates PD-L1 expression and modulates tumor immunity in KRAS-mutant non-small cell lung cancer. Int J Mol Sci. 2021;22(11):5649.
   Web of Science ®Google Scholar
• Maitra S, Bhattacharya D, Das S, et al. Melatonin and its anti-glioma functions: a comprehensive review. Rev Neurosci. 2019;30:527–541.
   PubMed Web of Science ®Google Scholar
• Jumnongprakhon P, Govitrapong P, Tocharus C, et al. Melatonin protects methamphetamine-induced neuroinflammation through NF-kappaB and Nrf2 pathways in glioma cell line. Neurochem Res. 2015;40:1448–1456.
   PubMed Web of Science ®Google Scholar
• Rajan B, Abunada T, Younes S, et al. Involvement of essential signaling cascades and analysis of gene networks in diabesity. Genes (Basel). 2020;11(11):1256.
   Web of Science ®Google Scholar
• Udhaya Kumar S, Thirumal Kumar D, Bithia R, et al. Analysis of differentially expressed genes and molecular pathways in familial hypercholesterolemia involved in atherosclerosis: a systematic and bioinformatics approach. Front Genet. 2020;11:734.
   PubMed Web of Science ®Google Scholar
• Fu D, Zhang B, Yang L, et al. Development of an immune-related risk signature for predicting prognosis in lung squamous cell carcinoma. Front Genet. 2020;11:978.
   PubMed Web of Science ®Google Scholar
• Carithers LJ, Moore HM. The Genotype-Tissue Expression (GTEx) project. Biopreserv Biobank. 2015;13:307–308.
   PubMed Web of Science ®Google Scholar
• Cooper LA, Demicco EG, Saltz JH, et al. PanCancer insights from The Cancer Genome Atlas: the pathologist’s perspective. J Pathol. 2018;244:512–524.
   PubMed Web of Science ®Google Scholar
• Goldman MJ, Craft B, Hastie M, et al. Visualizing and interpreting cancer genomics data via the Xena platform. Nat Biotechnol. 2020;38:675–678.
   PubMed Web of Science ®Google Scholar
• Gao J, Aksoy BA, Dogrusoz U, et al. Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci Signal. 2013;6:pl1.
   PubMed Web of Science ®Google Scholar
• Ito K, Murphy D. Application of ggplot2 to pharmacometric graphics. CPT Pharmacometrics Syst Pharmacol. 2013;2:e79.
   PubMedGoogle Scholar
• Gu Z, Gu L, Eils R, et al. circlize implements and enhances circular visualization in R. Bioinformatics. 2014;30:2811–2812.
   PubMed Web of Science ®Google Scholar
• Durisova M, Dedik L. SURVIVAL--an integrated software package for survival curve estimation and statistical comparison of survival rates of two groups of patients or experimental animals. Methods Find Exp Clin Pharmacol. 1993;15:535–540.
   PubMedGoogle Scholar
• Zhou Y, Zhou B, Pache L, et al. Metascape provides a biologist-oriented resource for the analysis of systems-level datasets. Nat Commun. 2019;10:1523.
   PubMed Web of Science ®Google Scholar
• Drier Y, Sheffer M, Domany E. Pathway-based personalized analysis of cancer. Proc Natl Acad Sci U S A. 2013;110:6388–6393.
   PubMed Web of Science ®Google Scholar
• Engebretsen S, Bohlin J. Statistical predictions with glmnet. Clin Epigenetics. 2019;11:123.
   PubMed Web of Science ®Google Scholar
• Koch HJ, Hau P. ROC analysis as an additional method to characterize time to event data. Pathol Oncol Res. 2005;11:50–52.
   PubMed Web of Science ®Google Scholar
• Rodriguez-Alvarez MX, Meira-Machado L, Abu-Assi E, et al. Nonparametric estimation of time-dependent ROC curves conditional on a continuous covariate. Stat Med. 2016;35:1090–1102.
   PubMed Web of Science ®Google Scholar
• Madden MH, Anic GM, Thompson RC, et al. Circadian pathway genes in relation to glioma risk and outcome. Cancer Causes Control. 2014;25:25–32.
   PubMed Web of Science ®Google Scholar
• Wang F, Chen Q. The analysis of deregulated expression of the timeless genes in gliomas. J Cancer Res Ther. 2018;14:S708–S712.
   PubMed Web of Science ®Google Scholar
• Udhaya Kumar S, Thirumal Kumar D, Siva R, et al. Dysregulation of signaling pathways due to differentially expressed genes from the B-cell transcriptomes of systemic lupus erythematosus patients - a bioinformatics approach. Front Bioeng Biotechnol. 2020;8:276.
   PubMed Web of Science ®Google Scholar
• Yan H, Zheng G, Qu J, et al. Identification of key candidate genes and pathways in multiple myeloma by integrated bioinformatics analysis. J Cell Physiol. 2019;234:23785–23797.
   PubMed Web of Science ®Google Scholar
• Kumar SU, Kumar DT, Siva R, et al. Integrative bioinformatics approaches to map potential novel genes and pathways involved in ovarian cancer. Front Bioeng Biotechnol. 2019;7:391.
   PubMed Web of Science ®Google Scholar
• Niranjan R, Nath C, Shukla R. Melatonin attenuated mediators of neuroinflammation and alpha-7 nicotinic acetylcholine receptor mRNA expression in lipopolysaccharide (LPS) stimulated rat astrocytoma cells, C6. Free Radic Res. 2012;46:1167–1177.
   PubMed Web of Science ®Google Scholar
• Bahna SG, Niles LP. Epigenetic induction of melatonin MT1 receptors by valproate: neurotherapeutic implications. Eur Neuropsychopharmacol. 2017;27:828–832.
   PubMed Web of Science ®Google Scholar
• Yang S, Chen X, Li S, et al. Melatonin treatment regulates SIRT3 expression in Early Brain Injury (EBI) due to Reactive Oxygen Species (ROS) in a Mouse Model of Subarachnoid Hemorrhage (SAH). Med Sci Monit. 2018;24:3804–3814.
   PubMed Web of Science ®Google Scholar
• Martin V, Herrera F, Carrera-Gonzalez P, et al. Intracellular signaling pathways involved in the cell growth inhibition of glioma cells by melatonin. Cancer Res. 2006;66:1081–1088.
   PubMed Web of Science ®Google Scholar
• Palmer ACS, Souza A, Dos Santos VS, et al. The effects of melatonin on the descending pain inhibitory system and neural plasticity markers in breast cancer patients receiving chemotherapy: randomized, double-blinded, placebo-controlled trial. Front Pharmacol. 2019;10:1382.
   PubMed Web of Science ®Google Scholar
• Wang Y, Liu X, Guan G, et al. A risk classification system with five-gene for survival prediction of glioblastoma patients. Front Neurol. 2019;10:745.
   PubMed Web of Science ®Google Scholar
• Alafate W, Zuo J, Deng Z, et al. Combined elevation of AURKB and UBE2C predicts severe outcomes and therapy resistance in glioma. Pathol Res Pract. 2019;215:152557.
   PubMed Web of Science ®Google Scholar